![]()
|
|
||||||||
J. Biol. Chem., Vol. 255, Issue 6, 2499-2508, 03, 1980
HH Samuels, F Stanley, J Casanova and TC Shao
The thyroid hormone receptor is a chromatin-associated protein which
appears to mediate the actions of the thyroid hormones in mammalian cells.
Unlike steroid hormone receptors, a cytoplasmic form of the receptor has
not been identified, and the factors which govern the nuclear
concentrations of the receptor are poorly understood. Using cultured GH1
cells, a rat pituitary cell line, we having previously demonstrated that
thyroid hormones reduces the concentration of its receptor by a mechanism
which involves the association of the ligand with the receptor binding site
(Samuels, H.H., Stanley, F., and Shapiro, L.E. (1977) J. Biol. Chem. 252,
6052-6060). In this study, we demonstrate that n-butyrate and other
aliphatic carboxylic acids elicit a reduction of thyroid hormone nuclear
receptor levels without altering total cell protein synthetic rates. In
contrast, the nuclear association and total cell level of the
glucocorticoid receptor is not altered by n-butyrate. Evidence is presented
that the aliphatic carboxylic acid-mediated reduction of thyroid hormone
nuclear receptor levels is secondary to the inhibitory effect of these
compounds on chromatin-associated deacetylases which is reflected as an
increase in the acetylation of the nucleosome core histones. Isokinetic
gradient centrifugation of chromatin solubilized from GH1 cell nuclei by
micrococcal nuclease indicates that the receptor exists as a form
associated with high molecular weight chromatin, as a 12.5 S form that
sediments slightly faster than the bulk of the mononucleosomes, and as a
6.5 S form which appears to remain associated with low molecular weight
chromatin components. Exclusive of the receptor associated with the high
molecular weight chromatin, the 6.5 S form represents 80% and the 12.5 S
form 10% of the receptor resolved in the gradient. n- Butyrate decreases
both forms to the same degree suggesting that they are generated from the
same "entity" of chromatin structure. Studies on the reappearance of
receptor after restoration of the chromatin to the "normal" acetylated
state are consistent with a model in which the affinity of chromatin for
newly synthesized receptor is diminished in the "hyperacetylated" state.
Thyroid hormone nuclear receptor levels are influenced by the acetylation of chromatin-associated proteins
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
K. Ranganna, T. Joshi, and F. M. Yatsu Sodium Butyrate Inhibits Platelet-Derived Growth Factor–Induced Proliferation of Vascular Smooth Muscle Cells Arterioscler. Thromb. Vasc. Biol., December 1, 1995; 15(12): 2273 - 2283. [Abstract] [Full Text] |
||||
![]() |
J Wong, Y B Shi, and A P Wolffe A role for nucleosome assembly in both silencing and activation of the Xenopus TR beta A gene by the thyroid hormone receptor. Genes & Dev., November 1, 1995; 9(21): 2696 - 2711. [Abstract] [PDF] |
||||
![]() |
D. Jump and J. Oppenheimer Thyroid hormone receptor-containing fragment released from chromatin by deoxyribonuclease I and micrococcal nuclease Science, August 15, 1980; 209(4458): 811 - 813. [Abstract] [PDF] |
||||
![]() |
I. Szanto and C. R. Kahn Selective interaction between leptin and insulin signaling pathways in a hepatic cell line PNAS, February 29, 2000; 97(5): 2355 - 2360. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |